AbstractCurrently, there is no adequate technology to detect early stage ovarian cancers. Most of the cancers in the ovary are detected when the cancer has already metastasized to other parts of the body. As a result, ovarian cancer has the highest mortality of all gynecologic cancers with a 5-year survival rate of 30% or less. Thus, there is an urgent need to improve the current diagnostic techniques. Photoacoustic imaging (PAI) is an emerging modality with a great potential to assist ultrasound for detecting ovarian cancer noninvasively. In this article, we report the first study of coregistered ultrasound and PAI of 33 ex vivo human ovaries. An assessment of the photoacoustic images has revealed light absorption distribution in the ovary...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
AbstractCurrently, there is no adequate technology to detect early stage ovarian cancers. Most of th...
Ovarian cancer has the highest mortality of all gynecologic cancers with a five-year survival rate o...
Ovarian cancer has the highest mortality of all gynecologic cancers with a five-year survival rate o...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is relatively rare but it has the highest mortality with a five-year survival rate of...
Ovarian cancer is relatively rare but it has the highest mortality with a five-year survival rate of...
Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging ar...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...
AbstractCurrently, there is no adequate technology to detect early stage ovarian cancers. Most of th...
Ovarian cancer has the highest mortality of all gynecologic cancers with a five-year survival rate o...
Ovarian cancer has the highest mortality of all gynecologic cancers with a five-year survival rate o...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is the fifth most common cancer among women and has the highest mortality rate of all...
Ovarian cancer is relatively rare but it has the highest mortality with a five-year survival rate of...
Ovarian cancer is relatively rare but it has the highest mortality with a five-year survival rate of...
Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging ar...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
Ovarian cancer ranks fifth as the cause of cancer death in women. Due to nonspecific associated symp...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdl...
Ovarian cancer is the fifth most common cause of death from cancer in women after lung, breast, colo...